Abstract
This study demonstrates successful hematopoietic stem cell transplant of CD40L deficiency using an asymptomatic carrier mother, leading to sustained 32% CD40L expression, normal recovery of T and B cell development and diversity, and expected growth and development 7.5 years post-transplant.
| Original language | English (US) |
|---|---|
| Article number | e20250212 |
| Journal | Journal of Human Immunity |
| Volume | 2 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 3 2026 |
Bibliographical note
Publisher Copyright:© 2026 Ebens et al.
PubMed: MeSH publication types
- Journal Article
Fingerprint
Dive into the research topics of 'Hematopoietic stem cell transplant with a carrier donor rescues CD40L deficiency'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS